- call +1-201-465-4211
- email sales@mrinsights.biz
Cholera vaccines are vaccines that are effective at preventing cholera. For the first six months after vaccination they provide about 85 percent protection, which decreases to 50 percent or 62 percent during the first year.
Scope of the Report:
This report studies the Cholera Vaccines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Cholera Vaccines market by product type and applications/end industries.
High disease incidence rate and increasing need for its prevention are some of the key factors expected to boost the market.
The global Cholera Vaccines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Cholera Vaccines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Shantha Biotechnics Private Limited
PaxVax, Inc.
Valneva SE
Merck & Co., Inc.
GlaxoSmithKline plc (GSK)
Astellas Pharma, Inc.
Pfizer, Inc.
Emergent BioSolutions, Inc.
Mitsubishi Tanabe Pharma Corporation
Takeda Pharmaceutical Co., Ltd.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Dukoral
Shanchol
Vaxchora
Others
Market Segment by Applications, can be divided into
Oral
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Cholera Vaccines Market Overview
1.1 Product Overview and Scope of Cholera Vaccines
1.2 Classification of Cholera Vaccines by Types
1.2.1 Global Cholera Vaccines Revenue Comparison by Types (2017-2023)
1.2.2 Global Cholera Vaccines Revenue Market Share by Types in 2017
1.2.3 Dukoral
1.2.4 Shanchol
1.2.5 Vaxchora
1.2.6 Others
1.3 Global Cholera Vaccines Market by Application
1.3.1 Global Cholera Vaccines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Oral
1.3.3 Others
1.4 Global Cholera Vaccines Market by Regions
1.4.1 Global Cholera Vaccines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Cholera Vaccines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Cholera Vaccines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cholera Vaccines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Cholera Vaccines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cholera Vaccines Status and Prospect (2013-2023)
1.5 Global Market Size of Cholera Vaccines (2013-2023)
2 Manufacturers Profiles
2.1 Shantha Biotechnics Private Limited
2.1.1 Business Overview
2.1.2 Cholera Vaccines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shantha Biotechnics Private Limited Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.2 PaxVax, Inc.
2.2.1 Business Overview
2.2.2 Cholera Vaccines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 PaxVax, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Valneva SE
2.3.1 Business Overview
2.3.2 Cholera Vaccines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Valneva SE Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Merck & Co., Inc.
2.4.1 Business Overview
2.4.2 Cholera Vaccines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Merck & Co., Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.5 GlaxoSmithKline plc (GSK)
2.5.1 Business Overview
2.5.2 Cholera Vaccines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 GlaxoSmithKline plc (GSK) Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Astellas Pharma, Inc.
2.6.1 Business Overview
2.6.2 Cholera Vaccines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Astellas Pharma, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer, Inc.
2.7.1 Business Overview
2.7.2 Cholera Vaccines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Emergent BioSolutions, Inc.
2.8.1 Business Overview
2.8.2 Cholera Vaccines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Emergent BioSolutions, Inc. Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Mitsubishi Tanabe Pharma Corporation
2.9.1 Business Overview
2.9.2 Cholera Vaccines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Mitsubishi Tanabe Pharma Corporation Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takeda Pharmaceutical Co., Ltd.
2.10.1 Business Overview
2.10.2 Cholera Vaccines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Takeda Pharmaceutical Co., Ltd. Cholera Vaccines Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cholera Vaccines Market Competition, by Players
3.1 Global Cholera Vaccines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Cholera Vaccines Players Market Share
3.2.2 Top 10 Cholera Vaccines Players Market Share
3.3 Market Competition Trend
4 Global Cholera Vaccines Market Size by Regions
4.1 Global Cholera Vaccines Revenue and Market Share by Regions
4.2 North America Cholera Vaccines Revenue and Growth Rate (2013-2018)
4.3 Europe Cholera Vaccines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Cholera Vaccines Revenue and Growth Rate (2013-2018)
4.5 South America Cholera Vaccines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Cholera Vaccines Revenue and Growth Rate (2013-2018)
5 North America Cholera Vaccines Revenue by Countries
5.1 North America Cholera Vaccines Revenue by Countries (2013-2018)
5.2 USA Cholera Vaccines Revenue and Growth Rate (2013-2018)
5.3 Canada Cholera Vaccines Revenue and Growth Rate (2013-2018)
5.4 Mexico Cholera Vaccines Revenue and Growth Rate (2013-2018)
6 Europe Cholera Vaccines Revenue by Countries
6.1 Europe Cholera Vaccines Revenue by Countries (2013-2018)
6.2 Germany Cholera Vaccines Revenue and Growth Rate (2013-2018)
6.3 UK Cholera Vaccines Revenue and Growth Rate (2013-2018)
6.4 France Cholera Vaccines Revenue and Growth Rate (2013-2018)
6.5 Russia Cholera Vaccines Revenue and Growth Rate (2013-2018)
6.6 Italy Cholera Vaccines Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Cholera Vaccines Revenue by Countries
7.1 Asia-Pacific Cholera Vaccines Revenue by Countries (2013-2018)
7.2 China Cholera Vaccines Revenue and Growth Rate (2013-2018)
7.3 Japan Cholera Vaccines Revenue and Growth Rate (2013-2018)
7.4 Korea Cholera Vaccines Revenue and Growth Rate (2013-2018)
7.5 India Cholera Vaccines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Cholera Vaccines Revenue and Growth Rate (2013-2018)
8 South America Cholera Vaccines Revenue by Countries
8.1 South America Cholera Vaccines Revenue by Countries (2013-2018)
8.2 Brazil Cholera Vaccines Revenue and Growth Rate (2013-2018)
8.3 Argentina Cholera Vaccines Revenue and Growth Rate (2013-2018)
8.4 Colombia Cholera Vaccines Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Cholera Vaccines by Countries
9.1 Middle East and Africa Cholera Vaccines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Cholera Vaccines Revenue and Growth Rate (2013-2018)
9.3 UAE Cholera Vaccines Revenue and Growth Rate (2013-2018)
9.4 Egypt Cholera Vaccines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Cholera Vaccines Revenue and Growth Rate (2013-2018)
9.6 South Africa Cholera Vaccines Revenue and Growth Rate (2013-2018)
10 Global Cholera Vaccines Market Segment by Type
10.1 Global Cholera Vaccines Revenue and Market Share by Type (2013-2018)
10.2 Global Cholera Vaccines Market Forecast by Type (2018-2023)
10.3 Dukoral Revenue Growth Rate (2013-2023)
10.4 Shanchol Revenue Growth Rate (2013-2023)
10.5 Vaxchora Revenue Growth Rate (2013-2023)
10.6 Others Revenue Growth Rate (2013-2023)
11 Global Cholera Vaccines Market Segment by Application
11.1 Global Cholera Vaccines Revenue Market Share by Application (2013-2018)
11.2 Cholera Vaccines Market Forecast by Application (2018-2023)
11.3 Oral Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)
12 Global Cholera Vaccines Market Size Forecast (2018-2023)
12.1 Global Cholera Vaccines Market Size Forecast (2018-2023)
12.2 Global Cholera Vaccines Market Forecast by Regions (2018-2023)
12.3 North America Cholera Vaccines Revenue Market Forecast (2018-2023)
12.4 Europe Cholera Vaccines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Cholera Vaccines Revenue Market Forecast (2018-2023)
12.6 South America Cholera Vaccines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Cholera Vaccines Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Cholera Vaccines Picture
Table Product Specifications of Cholera Vaccines
Table Global Cholera Vaccines and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
